Objectives
Understand the effectiveness, safety and tolerability of galcanezumab and differentiate in the appropriate patients.
PP-GZ-AE-0563
This Course For :
Physician
( Internal Medicine , Neurology , General practitioner )
Resident / Fellow
( Internal Medicine , Neurology , General practitioner )
Speaker
Prof. Piero Barbanti MD, PhD
Director, Headache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.
Associate Professor of Neurology, San Raffaele University, Rome, Italy.
Prof. Dagny Holle Lee MD, PhD
Neurologist and Head of Westgerman Headache and Vertigo Center, University Hospital Essen, Germany.
Prof. Stewart J. Tepper MD, FAHS
Professor of Neurology, Geisel School of Medicine, Dartmouth.
Director of the Dartmouth Headache Center in the Department of Neurology of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Provided by :
PP-IX-AE-0843
Note : This content is sponsored and approved by Eli Lilly and company (Lilly). This content is intellectual property of Lilly and its reproduction needs Lilly prior permission.
10 May 2023 To 10 May 2023 -
09:00 PM To 10:00 PM 
Certificate Available 
Online Click Here
- 9
Add to Calendar
05/10/2023 09:00 PM
05/10/2023 10:00 PM
Asia/ Riyadh
Advancing Migraine Prevention: Real World Experience on Galcanezumab
Advancing Migraine Prevention: Real World Experience on Galcanezumab
https://medicalacademy.org/portal/event/view/1953
